Ned Buttner1, Sujoy Bhattacharyya, John Walsh, Francine M Benes. 1. Laboratories for Structural Neuroscience, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States; Program in Neuroscience and Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
Abstract
UNLABELLED: Apoptosis is thought to contribute to neuronal loss in bipolar disorder and schizophrenia, although empiric evidence in support of this idea has been lacking. In this study, we investigated whether or not apoptosis is associated with GABAergic interneurons in the anterior cingulate cortex in schizophrenia (n=14) and bipolar disorder (n=14) when compared to normal controls (n=14). A double-labeling technique using the Klenow method of in situ end-labeling (ISEL) of single-stranded DNA breaks was combined with an in situ hybridization localization of mRNA for the 67 kDa isoform of glutamate decarboxylase (GAD67) and applied to the anterior cingulate cortex of 14 normal controls, 14 schizophrenics, and 14 patients with bipolar disorder matched for age and postmortem interval. An increase in Klenow-positive, GAD67-negative nuclei were observed in layer V/VI of patients with bipolar disorder, but not schizophrenics. Klenow-positive cells that were also positive for GAD67 mRNA did not show differences in either patient group. CONCLUSIONS: This is the first demonstration that there is more DNA fragmentation in cells showing no detectable GAD67 mRNA in patients with bipolar disorder than in schizophrenics or controls. These findings suggest that non-GABAergic cells may be selectively vulnerable to oxidative stress in patients with bipolar disorder.
UNLABELLED: Apoptosis is thought to contribute to neuronal loss in bipolar disorder and schizophrenia, although empiric evidence in support of this idea has been lacking. In this study, we investigated whether or not apoptosis is associated with GABAergic interneurons in the anterior cingulate cortex in schizophrenia (n=14) and bipolar disorder (n=14) when compared to normal controls (n=14). A double-labeling technique using the Klenow method of in situ end-labeling (ISEL) of single-stranded DNA breaks was combined with an in situ hybridization localization of mRNA for the 67 kDa isoform of glutamate decarboxylase (GAD67) and applied to the anterior cingulate cortex of 14 normal controls, 14 schizophrenics, and 14 patients with bipolar disorder matched for age and postmortem interval. An increase in Klenow-positive, GAD67-negative nuclei were observed in layer V/VI of patients with bipolar disorder, but not schizophrenics. Klenow-positive cells that were also positive for GAD67 mRNA did not show differences in either patient group. CONCLUSIONS: This is the first demonstration that there is more DNA fragmentation in cells showing no detectable GAD67 mRNA in patients with bipolar disorder than in schizophrenics or controls. These findings suggest that non-GABAergic cells may be selectively vulnerable to oxidative stress in patients with bipolar disorder.
Authors: M M Haznedar; M S Buchsbaum; C Luu; E A Hazlett; B V Siegel; J Lohr; J Wu; R J Haier; W E Bunney Journal: Am J Psychiatry Date: 1997-05 Impact factor: 18.112
Authors: Ana Cristina Andreazza; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Julio C Walz; David J Bond; Carlos A Gonçalves; L Trevor Young; Lakshmi N Yatham Journal: J Psychiatry Neurosci Date: 2009-07 Impact factor: 6.186
Authors: Amanda V Steckert; Samira S Valvassori; Morgana Moretti; Felipe Dal-Pizzol; João Quevedo Journal: Neurochem Res Date: 2010-05-25 Impact factor: 3.996
Authors: Mohammed S Mustak; Muralidhar L Hegde; Athira Dinesh; Gabrielle B Britton; Ruben Berrocal; K Subba Rao; N M Shamasundar; K S J Rao; T S Sathyanarayana Rao Journal: Indian J Psychiatry Date: 2010-07 Impact factor: 1.759
Authors: P Vasudevaraju; Jyothsna T; N M Shamasundar; K Subba Rao; B M Balaraj; Rao Ksj; Sathyanarayana Rao T S Journal: Indian J Psychiatry Date: 2010-04 Impact factor: 1.759
Authors: Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Kevin E Stanford; Chang-Gyu Hahn; Neil M Richtand Journal: Psychiatry Res Date: 2008-08-20 Impact factor: 3.222